ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Spondyloarthropathies"

  • Abstract Number: 2334 • ACR Convergence 2024

    Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS)

    Murat Torgutalp1, Valderilio Azevedo2, Xenofon Baraliakos3, Filip Van den Bosch4, Jürgen Braun5, Alberto Cauli6, Laura Coates7, Vinod Chandran8, Torsten Diekhoff9, Floris van Gaalen10, Rodrigo Garcia Salinas11, Lianne S Gensler12, Niti Goel13, Alice Gottlieb14, Desiree van der Heijde15, Philip Helliwell16, Kay Geert Hermann17, Umut Kalyoncu18, Uta Kiltz19, Robert Lambert20, Ying Ying Leung21, Maria Llop22, Alejandra Lopez23, Miranda van Lunteren24, Ajesh Maharaj25, Walter Maksymowych26, Helena Marzo-Ortega27, Ashish J Mathew28, Philip Mease29, Peter Nash30, Mikkel Ostergaard31, Fabian Proft32, Mikhail Protopopov33, Sherry Rohekar34, RUXANDRA ELENA SCHIOTIS35, Joachim Sieper36, Enrique R. Soriano37, Lai-shan Tam38, James Wei39, Nelly Ziade40, Dafna Gladman41 and Denis Poddubnyy42, and AXIS Cohort Investigators, 1Charite Universitatsmedizin - Berlin, Berlin, Germany, 2Department of Internal Medicine, Universidade Federal of Paraná, Curitiba, Brazil, Curitiba, Brazil, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 4Ghent University Hospital, Ghent, Belgium, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany., Herne, Germany, 6University of Cagliari, Cagliari, Italy, 7University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 8University of Toronto, Toronto, ON, Canada, 9Charite Universitatsmedizin Berlin, Berlin, Germany, 10LUMC, Leiden, Zuid-Holland, Netherlands, 11Hospital Italiano La Plata, La Plata, Argentina, 12Department of Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 13Caduceus Biomedical Consulting, Duke University, Durham, NC, 14Department of Dermatology, Icahn School of Medicine, New York, NY, USA., New York, NY, 15Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 16Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Leeds, United Kingdom, 17Charite Medical School, Berlin, Germany, 18Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 19Rheumazentrum Ruhrgebiet Herne, Ruhr-University, D-44649 Herne, Germany, 20University of Alberta, Edmonton, AB, Canada, 21Singapore General Hospital, Singapore, Singapore, 22Hospital Parc Tauli, Sabadell, Spain, 23Centro Dermatológico del Country, Guadalajara, Jalisco, Mexico, Guadalajara, Mexico, 24Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 25Department of Internal Medicine & Therapeutics, Faculty of Health Sciences. Walter Sisulu University, Eastern Cape, South Africa, Eastern Cape, South Africa, 26Department of Medicine, University of Alberta, Edmonton, AB, Canada; CARE Arthritis, Edmonton, AB, Canada, Edmonton, Canada, 27NIHR Leeds BRC, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Leeds, United Kingdom, 28Christian Medical College, Vellore, Tamil Nadu, India, 29Swedish Medical Center/Providence St. Joseph Health; University of Washington School of Medicine, Seattle, WA, 30School of Medicine, Griffith University, Sunshine Coast, Queensland, Australia, 31Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark, 32Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 33Charite – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 34Western University, London, Ontario, Canada, London, Canada, 35SPITAL CLINIC DE BOLI INFECTIOASE CLUJ NAPOCA, Cluj-Napoca, Romania, 36Charité University Medicine Berlin, Berlin, Germany, 37Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 38The Chinese University of Hong Kong, New Territories, Hong Kong, 39Chung Shan Medical University Hospital; China Medical University, Taichung, Taiwan (Republic of China), 40Saint-Joseph University, Beirut, Lebanon, 41University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 42Charite-Universitatsmedizin Berlin, Berlin, Germany

    Background/Purpose: Axial involvement, affecting the sacroiliac joints (SIJ) and/or spine, is a clinically relevant manifestation of psoriatic arthritis (PsA) that can influence management strategies. Previous…
  • Abstract Number: 0051 • ACR Convergence 2023

    CD14+CD64+ Classical Monocytes Are the Main Producers of IL-23 at the Enthesis

    Nicole McDermott1, Thomas Macleod1, Ala Altaie1, Liz Straszynski2, Robert Dunsmuir3, Vishal Borse3, Peter Loughenbury3, Davide Simone4, Stevephen Sansom4, Christopher Buckley4 and Dennis McGonagle5, 1University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Leeds Institute of Medical Research at St. James’s, Leeds, United Kingdom, 3Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom, 4Kennedy Institute of Rheumatology, Oxford, United Kingdom, 5Leeds Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: IL-23 is a key cytokine involved in diseases such as psoriasis, psoriatic arthritis and spondyloarthropathies (SpA) and inflammatory bowel disease.IL-23 is produced by activated…
  • Abstract Number: 1032 • ACR Convergence 2023

    “Not of Your Ethnicity”: A Qualitative Study Exploring Diverse Patient Experiences in Axial Spondyloarthritis (axSpA)

    Bryanna Mantilla1, K Wysham2, Jean liew3 and Grant Hughes1, 1University of Washington, Seattle, WA, 2VA Puget Sound/University of Washington, Seattle, WA, 3Boston University, Boston, MA

    Background/Purpose: Axial spondyloarthritis (axSpA) can result in significant morbidity. Existing studies suggest functional impairment and inflammation may be worse in Black and Latine patients. However,…
  • Abstract Number: 1880 • ACR Convergence 2023

    Performance of Machine Learning Algorithms in Discriminating Spondyloarthritis Features on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis

    Sun Jae Moon1, Seulkee Lee1, Seonyoung Kang1, Hyungjin Kim1, Jaejoon Lee1, Jinseok kim2, Eun-Mi Koh3, Jinseub Hwang4 and Hoon-Suk Cha1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, South Korea, 3Health Insurance Review and Assessment Service, Seoul, South Korea, 4Department of Data Science, Daegu University, Gyeongsan, South Korea

    Background/Purpose: The diagnostic role of Magnetic Resonance Imaging (MRI) for axial spondyloarthritis(axSpA) has grown since introducing the ASAS criteria for axSpA. Recent advances in machine…
  • Abstract Number: 0216 • ACR Convergence 2023

    High Immunogenicity of mRNA Covid-19 Vaccine Booster in Immune Mediated Inflammatory Disease

    Rebecca Haberman1, Rebecca Blank2, Paula Rackoff2, Gary Solomon3, Samrachana Adhikari1, Natalie Azar4, Ramin Herati1, Pamela Rosenthal5, Peter Izmirly6, Jonathan Samuels7, Brian Golden8, Soumya Reddy5, Mark Mulligan1 and Jose Scher6, 1NYU Grossman School of Medicine, New York, NY, 2New York University, New York, NY, 3NYU Langone School of Medicine, Hartsdale, NY, 4NYU Langone, New York, NY, 5NYU School of Medicine, New York, NY, 6New York University School of Medicine, New York, NY, 7NYU Langone, Rye Brook, NY, 8NYU Langone Medical Center - NYU Hospital for Joint Diseases, New York, NY

    Background/Purpose: Patients with immune-mediated inflammatory disorders (IMIDs) have an inherently heightened susceptibility to infection and may be considered high risk for COVID-19, yet IMID populations…
  • Abstract Number: 1346 • ACR Convergence 2023

    Semen Analysis of Patients with Psoriatic Arthritis, Axial Spondyloarthritis and Healthy Controls

    Katya Meridor1, Shimi Barda2, Ofir Elalouf2, Victoria Furer2, Sara Pel3, Hila Nochomovitz4, michael zisapel2, Jonathan Wollman2, Reut Tzemach2, Mark Berman5, Sara Borok6, Hagit Sarbagil-Maman7, Hagit Padova8, David levartovsky2, Tzippy Shochat9, Daphna Paran2, Ron Hauser2, Ori Elkayam2 and Ari Polachek6, 1Tel Aviv Medical Center, Kfar Saba, Israel, 2Tel Aviv Medical Center, Tel Aviv, Israel, 3Tel Aviv Medical Center, Modiin, Israel, 4Ichilov, Tel Aviv, Israel, 5Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 6Sourasky Medical Center, Tel Aviv, Israel, 7Tel Aviv Sourasky Medical center, Kiryat Ono, Israel, 8Tel Aviv Medical center, Petah-Tikva, Israel, 9Rabin Medical Center, Modiin, Israel

    Background/Purpose: Psoriatic arthritis (PsA) and axial spondyloarthritis (AxSpA) are commonly diagnosed in young males in their reproductive years. However, only a few studies have investigated…
  • Abstract Number: 1886 • ACR Convergence 2023

    Costotransverse Joint Ankylosis and Association with Syndesmophyte Progression in Patients with Radiographic Axial Spondyloarthritis

    Hong Ki Min1, Se Hee Kim2, Hae-Rim Kim3, Sang-Heon Lee1 and Sang-Hoon Lee2, 1Konkuk University School of Medicine, Seoul, South Korea, 2Kyung Hee University Hospital at Gangdong, Seoul, South Korea, 3Rheumatology, Konkuk University Medical Center, Seoul, South Korea

    Background/Purpose: Costotransverse joint ankylosis in radiographic axial spondyloarthritis (r-axSpA) patients was measured. Furthermore, the association between syndesmophyte progression assessed by CT syndesmophyte score (CTSS) and…
  • Abstract Number: 0452 • ACR Convergence 2023

    Real Life Safety and Survival of Targeted Therapies in Arthritis Patients over Age of 65

    Elena Grau Garcia1, Pablo Francisco Muñoz Martínez2, Laura Mas Sanchez3, Alba Maria Torrat Noves1, Daniel Ramos Castro1, Carmen Riesco Barcena1, Anderson Victor Huaylla Quispe1, Iago Alcantara Alvarez1, Belen Villanueva Mañez1, Samuel Leal Rodriguez1, Ines Canovas Olmos1, Hikmat Charia1, Marta De la Rubia Navarro1, Luis Gonzalez Puig1, Jose Ivorra Cortes1, Isabel Martinez Cordellat1, Carmen Najera Herranz1, Rosa Negueroles Albuixech1, Jose Eloy Oller Rodriguez1, Ernesto Tovar Sugrañes1, Elvira Vicens Bernabeu1 and Jose Andres Roman Ivorra4, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Rheumatology Department. HUP La Fe, Sagunto, Spain, 3Rheumatology Department. HUP La Fe, Valéncia, Spain, 4Hospital Universitari i Politècnic la Fe, Valencia, Spain

    Background/Purpose: Prognosis for chronic inflammatory arthritis is drastically improved over previous decades and older patients are treated with targeted therapies (TTs) (biological or synthetic targeted…
  • Abstract Number: 1392 • ACR Convergence 2023

    Improving the Diagnostic Accuracy in Axial Spondyloarthritis: Interim Results of a Nationwide Telemedicine Project

    Denis Poddubnyy1, Marc Kämmerer2, Marcus Kremers3, Berit Schoppen3, Charlotte Arens3, Annette Wiedon4, Imke Redeker5 and Xenofon Baraliakos6, 1Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2VISUS Health IT GmbH, Bochum, Germany, 3MedEcon Telemedizin GmbH / MedEcon Ruhr GmbH, Bochum, Germany, 4Novartis Pharma GmbH, Nürnberg, Germany, 5Ruhr Universität Bochum, Bochum, Germany, 6Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is often diagnosed late, while there is also a problem of over- and misdiagnosis in patients with chronic back pain. Imaging,…
  • Abstract Number: 1892 • ACR Convergence 2023

    Sacroiliac Bone Marrow Oedema on Postpartum MRI Does Not Result in Significant SpA-like Structural Lesions: Results of a 5-year Follow-up Study

    De Meester Liesbet1, Gaelle Varkas2, Manouk de Hooge3, Ann-Sophie De Craemer4, Nele Herregods5, Lennart Jans5, Philippe Carron6, Dirk Elewaut7 and Filip Van den Bosch8, 1Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 2Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Ghent University Hospital, Hesperange, Luxembourg, 4Ghent University Hospital, Gent, Belgium, 5Department of Radiology, Ghent University Hospital, Ghent, Belgium, 6UZ Gent, Gent, Belgium, 7Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 8Department of Internal Medicine and Pediatrics, Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

    Background/Purpose: Sacroiliac bone marrow oedema (BMO) on MRI, immediately after childbirth, has been observed in a large proportion of postpartum women and appears to be…
  • Abstract Number: 0484 • ACR Convergence 2023

    Higher Levels of High-sensitivity CRP Are Associated with Future Risk of Developing Psoriatic Arthritis Among Patients with Psoriasis: A Prospective Cohort Study

    Lihi Eder1, Vinod Chandran2, Cheryl Rosen3, Richard J. Cook4 and Dafna Gladman5, 1Women’s College Research Institute, Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 2Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Division of Dermatology, Toronto Western Hospital, Toronto, ON, Canada, 4Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Simple and accessible biomarkers that predict the development of psoriatic arthritis (PsA) among psoriasis patients are critically needed to improve early detection of high-risk…
  • Abstract Number: 1398 • ACR Convergence 2023

    A Deep Learning Algorithm for MRI Spinal Inflammation in Axial Spondyloarthritis

    Shirley Chiu Wai Chan1, Ying Ying Lin2, Ho Yin Chung1, Kam Ho Lee3 and Peng Cao2, 1Divison of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong, Hong Kong, 2Department of Diagnostic Radiology, the University of Hong Kong, Hong Kong, Hong Kong, 3Department of Radiology, Queen Mary Hospital, Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Deep learning has achieved wide applications in different areas of medical imaging analysis. Limited studies have explored the use of deep learning for imaging…
  • Abstract Number: 2199 • ACR Convergence 2023

    Four-year Secukinumab Treatment Outcomes in Axial Spondyloarthritis and Psoriatic Arthritis Patients Treated in Routine Care: Results from the EuroSpA Collaboration

    Marion Pons1, Stylianos Georgiadis1, Zohra Faizy Ahmadzay2, Mikkel Østergaard3, Bente Glintborg1, Jette Heberg1, Sara Nysom Christiansen1, Simon Horskjær Rasmussen1, Isabel Castrejon4, Fernando Alonso5, Karin Laas6, Sigrid Vorobjov7, Nikita Khmelinskii8, Jakub Zavada9, Adrian Ciurea10, Michael Nissen11, Brigitte Michelsen12, Pawel Mielnik13, Anne Gitte Loft14, Ziga Rotar15, Katja Perdan Pirkmajer16, Gary Macfarlane17, Gareth T. Jones17, Dan Nordstrom18, Anna-Mari Hokkanen19, Irene van der Horst-Bruinsma20, Johan Karlsson Wallman21, Bjorn Gudbjornsson22, olafur Palsson23, Merete Hetland1 and Lykke Ørnbjerg1, 1Copenhagen Center for Arthritis Research, Rigshospitalet, Copenhagen, Denmark, 2Rigshospitalet Glostrup, University of Copenhagen, Glostrup, Denmark, 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; University of Copenhagen, Copenhagen, Denmark, 4Hospital Universitario Gregorio Marañón, Madrid, Spain, 5Spanish Society of Rheumatology, Madrid, Spain, 6Department of Rheumatology, East-Tallinn Central Hospital, Tallinn, Estonia, 7National Institute for Health Development, Tallinn, Estonia, 8Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 9Institute of Rheumatology; Charles University, Prague, Czech Republic, 10University Hospital Zurich, Zürich, Switzerland, 11Geneva University Hospitals, Geneva, Switzerland, 12Rigshospitalet Glostrup; Diakonhjemmet Hospital; Sørlandet Hospital, Copenhagen, Denmark, 13Section for Rheumatology, Helse Førde, Førde, Norway, 14Aarhus University, Horsens, Denmark, 15University Medical Centre Ljubljana, Ljubljana, Slovenia, 16University Medical Centre Ljubljana; University of Ljubljana, Ljubljana, Slovenia, 17Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 18Helsinki University Hospital, Helsinki, Finland, 19Departments of Medicine and Rheumatology, Helsinki University Hospital, Helsinki, Finland, 20Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 21Lund University and Skåne University Hospital, Lund, Sweden, 22Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland, 23Faculty of Medicine, University of Iceland, Reykjavik, Iceland

    Background/Purpose: Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are part of the spondylarthritis spectrum that can be treated with secukinumab, a fully human IgG1 monoclonal…
  • Abstract Number: 0493 • ACR Convergence 2023

    Axial Disease Activity in Psoriatic Arthritis Is Higher in Patients with Carotid Plaque

    Rosa Arvizu-Rivera1, Valeria Gonzalez-Gonzalez2, Dionicio A. Galarza-Delgado3, Iris Colunga3, José Ramón Azpiri-López3, Victor Beltran4, Angel Arias Peralta5 and Jesus Alberto Cardenas-De la Garza6, 1Hospital Universitario "Dr. José Eleuterio Gonzalez", Escobedo, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Hospital Universitario UANL, Monterrey, Mexico, 4Rheumatology Service Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 5Medicine Faculty, Universidad Autonoma De Nuevo Leon, Monterrey, Mexico, 6Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico

    Background/Purpose: Approximately half of the patients with psoriatic arthritis (PsA) present with axial disease. Previously, it was reported that PsA-patients with axial involvement present a…
  • Abstract Number: 1405 • ACR Convergence 2023

    Diagnostic Delay of Axial Spondyloarthritis in African American Patients

    John Byun1, Hans Vitzthum von Eckstaedt1, Kichul Ko2 and Reem Jan1, 1University of Chicago, Chicago, IL, 2The University of Chicago, Chicago, IL

    Background/Purpose: The identification of axial spondyloarthritis (axSpA) remains challenging. The initial presentation is not always immediately apparent as an inflammatory disease, potentially leading to years…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology